Cell Therapies vs Omniabio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/celltherapies/omniabio

Category	Cell Therapies	Omniabio
Listed site	cdmo	cdmo
Summary	GMP contract manufacturer of autologous and allogeneic cell therapies from first-in-human trials through commercial supply, with two decades of experience in CAR-T, mesenchymal stromal cells, TILs, and pluripotent stem cell derivatives. Offers end-to-end cold chain management, process development, quality control analytics, and regulatory consulting across Australia and Asia-Pacific.	OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.
Services	Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Technology Transfer Process Development CMC Analytical Development Quality Control Testing Cold-Chain Storage & Logistics CMC Regulatory Submission Support	Process Development CMC Analytical Development Cell-Line Development Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Cell Therapy Manufacturing Lentiviral Vector Manufacturing CMC Regulatory Submission Support
Modalities	Cell Therapy Gene Therapy	Cell Therapy Gene Therapy
Indications	Oncology	Data not yet provided.
Locations	Headquarters / Manufacturing & Development, Melbourne, Victoria, Australia	Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada
Certifications	TGA · Identifier: TGA-licensed FDA · Identifier: FDA inspection-ready PMDA · Identifier: PMDA inspection-ready EMA · Identifier: EMA inspection-ready	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.